Stay updated with breaking news from Robert Wasserman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Benchmark analyst Robert Wasserman reiterated a Buy rating on AbCellera Biologics Inc. (NASDAQ: ABCL),
Benchmark analyst Robert Wasserman reiterated a Buy rating on AbCellera Biologics Inc. ABCL, lowering the price target to $12 on reduced valuations for other…
New Bedford Police report, prepared over 18 months, recommends measures to modernize the department, and improve performance.
The New Bedford Police Department announced on Thursday the findings of a two-year comprehensive review of the department's policies and conduct.
Emergent BioSolutions Inc. (EBS) shares are gaining more than 10 percent on Monday morning after Analyst Robert Wasserman raised the rating from Hold to Buy with price target of $22.